![Wegovy CV risk reduction data in obesity could help both Novo Nordisk and Eli Lilly (NVO) | Seeking Alpha Wegovy CV risk reduction data in obesity could help both Novo Nordisk and Eli Lilly (NVO) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1219304819/image_1219304819.jpg?io=getty-c-crop-4-3)
Wegovy CV risk reduction data in obesity could help both Novo Nordisk and Eli Lilly (NVO) | Seeking Alpha
![$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption - Genetic Literacy Project $1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption - Genetic Literacy Project](https://geneticliteracyproject.org/wp-content/uploads/2021/07/wegovy.jpeg)
$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption - Genetic Literacy Project
![Weekly injectable weight loss drug Wegovy is a huge hit and in short supply - Genetic Literacy Project Weekly injectable weight loss drug Wegovy is a huge hit and in short supply - Genetic Literacy Project](https://geneticliteracyproject.org/wp-content/uploads/2021/11/Wegovy-x-.png)
Weekly injectable weight loss drug Wegovy is a huge hit and in short supply - Genetic Literacy Project
![Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks | Daily Mail Online Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks | Daily Mail Online](https://i.dailymail.co.uk/1s/2023/02/02/19/64540469-11706885-Wegovy_is_a_GLP_1_drug_that_has_been_heralded_for_its_value_as_a-a-29_1675364465395.jpg)